r/biotech
Novartis ends ALS program after phase 2 flop, adding to R&D woes
- upvotes
- 56
- comments
- 1
Extracted from these lines
[comment u/OrangeNo2255] Oh Giovanni! You failed BMS and now you fail Novartis! Talk about failing up!
Post: "Novartis ends ALS program after phase 2 flop, adding to R&D woes"
r/biotech
Extracted from these lines
[comment u/OrangeNo2255] Oh Giovanni! You failed BMS and now you fail Novartis! Talk about failing up!
“Oh Giovanni! You failed BMS and now you fail Novartis! Talk about failing up!”
u/OrangeNo22551 points · Sep 20, 2026View
What this signalsUser posts often show product pain before it reaches reviews or churn.
Topics
Flair
reddit-companyproductChangeGet every Reddit signal for Novartis and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Novartis this week?”
The Signal API returns Reddit signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full reddit-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/caf7e8d8-3703-5569-afd3-67b5c8890989 returns this record as JSON. POST /v1/companies/enrich returns every signal for novartis.com.
{
"signal_id": "caf7e8d8-3703-5569-afd3-67b5c8890989",
"signal_type": "reddit-company",
"signal_subtype": "productChange",
"detected_at": "2026-09-16T14:53:57+00:00",
"company": {
"name": "Novartis",
"domain": "novartis.com"
},
"data": {
"nsfw": false,
"stage": "confirmed",
"awards": 0,
"timing": "completed",
"topics": [
"r&d",
"clinical trials",
"drug development",
"pharma",
"als"
],
"post_id": "1whzhyv",
"summary": "Novartis has discontinued its Amyotrophic Lateral Sclerosis (ALS) program following a failure in its phase 2 clinical trial, adding to its R&D challenges.",
"category": "discontinued",
"comments": [
{
"url": "https://www.reddit.com/r/biotech/comments/1whzhyv/comment/pav5m2o/",
"depth": 0,
"score": 1,
"author": "OrangeNo2255",
"excerpt": "Oh Giovanni! You failed BMS and now you fail Novartis! Talk about failing up!",
"posted_at": "2026-09-20T00:01:11.000Z",
"author_url": "https://www.reddit.com/user/OrangeNo2255/"
}
],
"evidence": [
"[post] Novartis ends ALS program after phase 2 flop, adding to R&D woes",
"[comment u/OrangeNo2255] Oh Giovanni! You failed BMS and now you fail Novartis! Talk about failing up!"
],
"link_url": "https://www.fiercebiotech.com/biotech/novartis-ends-als-program-after-phase-2-flop-adding-rd-woes",
"virality": "medium",
"post_date": "2026-09-16T14:53:57.000Z",
"post_kind": "link",
"sentiment": "negative",
"subreddit": "biotech",
"event_date": "2026-09",
"post_flair": [
"Biotech News 📰"
],
"post_title": "Novartis ends ALS program after phase 2 flop, adding to R&D woes",
"prominence": "core",
"source_url": "https://www.reddit.com/r/biotech/comments/1whzhyv/novartis_ends_als_program_after_phase_2_flop/",
"entity_role": "subject",
"post_author": "NotGenentech",
"upvote_ratio": 1,
"mention_count": 2,
"mention_surge": false,
"subreddit_url": "https://www.reddit.com/r/biotech/",
"total_upvotes": 56,
"comments_total": 1,
"total_comments": 1,
"post_author_url": "https://www.reddit.com/user/NotGenentech/",
"signal_category": "event",
"comments_included": 1
}
}
curl https://signals.autobound.ai/v1/signals/caf7e8d8-3703-5569-afd3-67b5c8890989 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"novartis.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.